Colorectal Cancer
📧 Sign up to get email alerts when something new happens for Colorectal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-12-12Clinical Trial Update: GEN1029 (HexaBody®-DR5/DR5) Safety Trial in Patients With Malignant Solid Tumors [Phase 1, Phase 2]
Phase 1/2 safety trial of GEN1029 (HexaBody-DR5/DR5) in malignant solid tumors (termina ted; results posted in 2022).
-
CLINICAL_TRIALS trial_result · 2022-12-05Clinical Trial Update: Study of Durvalumab and Tremelimumab After Radiation for Microsatellite Stable Metastatic Colorectal Cancer Progressing on Chemotherapy [Phase 2]
Phase 2 trial evaluating durvalumab and tremelimumab after radiation in microsatellite stable metastatic colorectal cancer progressing on ch…
-
CLINICAL_TRIALS trial_result · 2022-12-02Clinical Trial Update: The Efficacy and Safety of Fruquintinib Plus FOLFIRI/FOLFOX as Second-line Treatment in Patients With RAS-mutant Metastatic Colorectal Cancer [Phase 2]
Phase 2 trial investigating Fruquintinib with FOLFIRI/FOLFOX as second-line therapy for RAS-mutant metastatic colorectal cancer; efficacy an…
-
CLINICAL_TRIALS trial_result · 2022-12-01Clinical Trial Update: Skin Rash Study Before Chemotherapy in Colorectal & Head and Neck Cancer Patients [Phase 2]
Phase 2 clinical trial evaluating skin rash management before chemotherapy in colorectal and head and neck cancer patients has completed.
-
CLINICAL_TRIALS trial_result · 2022-11-29Clinical Trial Update: Donafenib for Previously Treated Metastatic Colorectal Cancer [Phase 3]
A Phase 3 clinical trial update for donafenib in previously treated metastatic colorectal cancer has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-11-17Clinical Trial Update: Mechanical Bowel Preparation and Oral Antibiotics Versus Mechanical Bowel Preparation Only Prior Rectal Surgery [Phase 4]
Phase 4 clinical trial evaluating mechanical bowel preparation with oral antibiotics versus mechanical bowel preparation alone prior to rect…
-
CLINICAL_TRIALS trial_result · 2022-11-17Clinical Trial Update: A Study of RO5083945 in Combination With FOLFIRI Versus FOLFIRI Plus Cetuximab or FOLFIRI Alone as Second Line Treatment in Patients With Metastatic Colorectal Cancer [Phase 2]
Phase 2 trial evaluating RO5083945 with FOLFIRI versus FOLFIRI plus cetuximab or FOLFIRI alone as second-line therapy in metastatic colorect…
-
CLINICAL_TRIALS trial_result · 2022-11-14Clinical Trial Update: To Evaluate the Safety, Tolerability, Pharmacokinetics and Antitumor Activity of YYB101 With Irinotecan, Patients Who Are Metastatic or Recurrent Colorectal Cancer Patients [Phase 1, Phase 2]
Phase 1/2 trial evaluating YYB101 with irinotecan in metastatic or recurrent colorectal cancer has completed.
-
CLINICAL_TRIALS trial_result · 2022-11-09Clinical Trial Update: Surufatinib With or Wothout Immunotherapy for Advanced Colorectal Cancer in Later Line [Phase 2]
Phase 2 trial investigating surufatinib with or without immunotherapy for advanced colorectal cancer in later-line settings.
-
CLINICAL_TRIALS trial_result · 2022-10-26Clinical Trial Update: Fruquintinib Combined With mFOLFOX6/FOLFIRI in First-line Treatment for Metastatic Colorectal Cancer [Phase 2]
Phase 2 trial investigating fruquintinib combined with mFOLFOX6/mFOLFIRI as first-line treatment for metastatic colorectal cancer.
-
CLINICAL_TRIALS trial_result · 2022-10-21Clinical Trial Update: Disitamab Vedotin Combined With Tislelizumab in Advanced HER2 Positive Colorectal Cancer [Phase 2]
Phase 2 clinical trial update evaluating disitamab vedotin with tislelizumab in advanced HER2-positive colorectal cancer.
-
CLINICAL_TRIALS trial_result · 2022-10-20Clinical Trial Update: S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER) [NA]
Clinical trial update for S1415CD (TrACER) reporting completed status with results posted; study involves CSF prescribing effectiveness and …
-
CLINICAL_TRIALS trial_result · 2022-10-20Clinical Trial Update: Preoperative Nivolumab Plus Bevacizumab Combined With Chemotherapy Before Surgery in Patients With pMMR/MSS Colorectal Cancer Liver Metastases [Phase 2]
Phase 2 trial update evaluating preoperative nivolumab plus bevacizumab with chemotherapy before surgery in patients with mismatch repair pr…
-
FDA approval · 2022-10-18FDA Approved: FLUOROURACIL — Supplemental Application (Taro Pharmaceuticals U.S.A., Inc.)
FDA approved a supplemental application for fluorouracil submitted by Taro Pharmaceuticals U.S.A., Inc., approving changes to the product’s …
-
CLINICAL_TRIALS trial_result · 2022-10-18Clinical Trial Update: Multilevel Intervention Based on Colorectal Cancer (CRC) and Cervical Cancer Self-screening in Rural, Segregated Areas [NA]
Completed clinical trial evaluating multilevel interventions for self-screening in rural areas for colorectal and cervical cancer; results p…
-
CLINICAL_TRIALS trial_result · 2022-10-13Clinical Trial Update: Phase 2 Study of Thermodox as Adjuvant Therapy With Thermal Ablation (RFA) in Treatment of Metastatic Colorectal Cancer(mCRC) [Phase 2]
Phase 2 study of Thermodox with radiofrequency ablation in metastatic colorectal cancer was terminated; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-10-12Clinical Trial Update: A Safety and Effectiveness Study of Pre-operative Artesunate in Stage II/III Colorectal Cancer [Phase 2]
A Phase 2 safety and effectiveness trial evaluating pre-operative artesunate in Stage II/III colorectal cancer is underway, with status curr…
-
CLINICAL_TRIALS trial_result · 2022-10-12Clinical Trial Update: HepaSphere™ Microspheres Prospective Registry
Prospective registry study update for HepaSphere microspheres in metastatic colorectal cancer has been completed with results posted in 2022…
-
CLINICAL_TRIALS trial_result · 2022-10-07Clinical Trial Update: Adjuvant mFOLFOXIRI vs. mFOLFOX6 in MRD Positive Stage II-III Colorectal Cancer (AFFORD) [Phase 3]
Phase 3 trial comparing adjuvant mFOLFOXIRI versus mFOLFOX6 in MRD-positive stage II-III colorectal cancer (AFFORD) awaiting recruitment.
-
CLINICAL_TRIALS trial_result · 2022-10-07Clinical Trial Update: Oral Lactobacillus Rhamnosus TCELL-1 and Colorectal Cancer [Phase 2]
A Phase 2 clinical trial update investigating oral Lactobacillus rhamnosus TCELL-1 as an adjuvant therapy in staged III colorectal cancer pa…
-
CLINICAL_TRIALS trial_result · 2022-10-03Clinical Trial Update: Trial of Active Immunotherapy With OBI-833 (Globo H-CRM197) in Advanced/Metastatic Gastric, Lung, Colorectal or Breast Cancer Subjects [Phase 1]
Phase 1 trial of active immunotherapy OBI-833 (Globo H-CRM197) in metastatic gastric, breast, colorectal, and lung cancer has completed with…
-
CLINICAL_TRIALS trial_result · 2022-09-29Clinical Trial Update: Avelumab and Cetuximab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer - The Phase II AVETUX-CRC Trial. [Phase 2]
Phase II trial AVETUX-CRC studied avelumab plus cetuximab with FOLFOX in previously untreated metastatic colorectal cancer; the study is com…
-
CLINICAL_TRIALS trial_result · 2022-09-28Clinical Trial Update: Problem Solving Skills Training in Adult Cancer Survivors: Bright IDEAS-AC [NA]
Clinical trial update for Bright IDEAS-AC evaluating problem solving skills training in adult cancer survivors; study completed with results…
-
CLINICAL_TRIALS trial_result · 2022-09-22Clinical Trial Update: Envafolimab Combined With Endostatin in Recurrent or Metastatic MSS-type Colorectal Cancer [Phase 2]
Phase 2 trial evaluating Envafolimab with Endostatin in recurrent or metastatic MSS-type colorectal cancer.
-
CLINICAL_TRIALS trial_result · 2022-09-15Clinical Trial Update: VIC Regimen Versus Bevacizumab Plus Chemotherapy as First-Line Treatment for BRAF V600E-Mutated Advanced Colorectal Cancer [Phase 3]
Phase 3 trial comparing VIC regimen to bevacizumab plus chemotherapy as first-line treatment for BRAF V600E-mutated advanced colorectal canc…